Evidence map›Paper›PMID 30631597›Full record

ReviewTuberculosis research and treatment2018

Thato Iketleng, Richard Lessells, Mlungisi Thabiso Dlamini, Tuelo Mogashoa, Lucy Mupfumi, Sikhulile Moyo, Simani Gaseitsiwe, Tulio de Oliveira

Open access · hybridAbstract readReview
In one paragraph

Review in Tuberculosis research and treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Decoding EcuadorianBiomedicines · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Culture-Free Whole Genome Sequencing ofOpen forum infectious diseases · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Rapid Identification ofFrontiers in microbiology · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Thato IketlengCollege of Health Sciences, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0002-5725-295X
Richard LessellsKwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa.
Mlungisi Thabiso DlaminiKwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa.
Tuelo MogashoaBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Lucy MupfumiBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.ORCID 0000-0002-2290-2481
Sikhulile MoyoBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Simani GaseitsiweBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Tulio de OliveiraKwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa.
University of KwaZulu-Natal · ZAHarvard University · USUniversity of Botswana · BWBotswana Harvard AIDS Institute Partnership · BW

Funding

Training in HIV Genomics, Treatment, and Cure Research in BotswanaD43TW009610 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI SHAHIN LOCKMAN, Joseph Moeketsi Makhema · 2013 to 2026
$4.4M
FIC NIH HHS D43 TW009610
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30631597
PMCPMC6304523
OpenAlexW2904468481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.